Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...

Our research aims to understand the underlying causes of dementia, advance dementia diagnosis, improve care, and search for a cure. Research will beat dementia and will lead to improved diagnosis, ...

Spear Bio Inc., a biotechnology company pioneering next-generation ultra-sensitive immunoassays, today announced that its pTau 217 blood test has been granted Breakthrough Device Designation by the U.

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

While the Alzheimer’s market is projected to experience strong growth throughout the forecast period across the 8MM, unmet ...

The small miracles that 2024 brought to our lives lay the groundwork for new revolutionary treatments that are being prepared ...

Cambridge, Massachusetts Monday, January 13, 2025, 15:00 Hrs [IST] ...

Targeting toxic oligomers without binding to plaque, designed to reduce the risk of ARIA and potentially deliver enhanced ...

According to Alzheimer’s Disease International and Dementia Forecasting Collaborators, Alzheimer’s Disease is currently the ...